Overview

Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, double blind, parallel group placebo controlled randomised trial designed to determine the safety and efficacy of a Standardised Extract of Phyllanthus Niruri (EPN 797) HEPAR-P capsule for the treatment of Non-alcoholic Fatty Liver Disease for a treatment period of 48 weeks
Phase:
Phase 2
Details
Lead Sponsor:
Nova Laboratories Sdn Bhd